Breaking News
Black Friday SALE: Up to 54% off InvestingPro! Register here
Investing Pro 0
Ad-Free Version. Upgrade your experience. Save up to 40% More details

Democratic lawmaker presses antitrust enforcers on company ties, settlements

Stock MarketsJan 07, 2020 07:43PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items

WASHINGTON (Reuters) - The chair of the U.S. House of Representatives antitrust subcommittee pressed top regulators on Tuesday over merger decisions, including the Justice Department's approval of T-Mobile US Inc's (O:TMUS) proposed purchase of Sprint Corp (N:S).

Congressman David Cicilline raised antitrust questions as activists and Democratic presidential candidates are advocating for more aggressive enforcement of rules governing market concentration and corporate behavior.

In questions posted on a House website, Cicilline asked Makan Delrahim, head of the Justice Department's Antitrust Division, about text messages he had sent to Dish Network Corp (O:DISH) Chairman Charlie Ergen, who plans to buy assets that T-Mobile and Sprint would sell as part of an agreement to win federal approval for their deal.

The planned merger of the third and fourth largest wireless providers is being challenged by state attorneys general, led by California and New York. A trial in New York is underway.

Cicilline noted that Delrahim wrote to Ergen: "Today would be a good day to have your Senator friends contact the chairman," a reference to the chair of the Federal Communications Commission which has since approved the merger.

Cicilline asked Delrahim if he had offered lobbying advice to other merging companies and if it was appropriate to offer such advice.

Cicilline also pressed the antitrust chief on a report that the Trump administration has brought fewer criminal antitrust cases, essentially price-fixing, than any in 50 years. "Is it your view that market participants are no longer engaging in price-fixing at the rates they previously had?" Cicilline asked.

Cicilline asked Federal Trade Commission Chairman Joe Simons about the November approval of Bristol-Myers Squibb Co's (N:BMY) $74 billion purchase of Celgene (NASDAQ:CELG) on the condition it divest the drug Otezla.

Cicilline asked the agency whether its practice of focusing on product overlap is enough when analyzing this and other pharmaceutical mergers.

Cicilline also pressed Simons on the FTC's record $5 billion settlement with Facebook Inc (O:FB) for the social media company's violation of an earlier settlement with the agency. He cited criticism that Facebook Chief Executive Mark Zuckerberg was not held responsible for the order violations.

"What is the Commission doing to ensure that CEOs of large companies are held accountable when their companies violate antitrust law with the CEOs' knowledge or at his or her direction?," Cicilline asked.

An FTC spokesman declined to comment. A Justice Department spokesman did not immediately respond to a request for comment.

Democratic lawmaker presses antitrust enforcers on company ties, settlements

Related Articles

What to Make of the Recent Stock Market Pullback?
What to Make of the Recent Stock Market Pullback? By StockNews - Nov 27, 2021

I had written up a commentary that I intended to send out this morning that was going to focus on some bigger-picture, strategic items related to market cycles and developing...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email